Advertisement
Advertisement
COSM
Cosmos Holdings Inc. Common Stock
0.20
USDSponsored
-0.07
-26.14%
Nov 10, 15:59 UTC -5
Closed
After-Market
0.20
0.00
+1.62%
Cosmos Holdings Inc. Common Stock (COSM) Earnings
COSM Earnings Reports
Positive Surprise Ratio
COSM beat 1 of 7 last estimates.
14%
Next Report
Next Week
Date of Next Report
Nov 17, 2026
Estimate for Q3 26 (Revenue/ EPS)
$17.70M
/-$0.04
Implied change from Q2 26 (Revenue/ EPS)
-6.79%
/-60.00%
Implied change from Q3 25 (Revenue/ EPS)
--
/--
Cosmos Holdings Inc. Common Stock earnings per share and revenue
On Aug 18, 2026, COSM reported earnings of -0.10 USD per share (EPS) for Q2 26, missing the estimate of 0.01 USD, resulting in a -1080.39% surprise. Revenue reached 18.99 million, compared to an expected 19.81 million, with a -4.15% difference. The market reacted with a -6.58% price change (close before vs. close after earnings).
Looking ahead to Q3 26, -- analysts forecast an EPS of -0.04 USD, with revenue projected to reach 17.70 million USD, implying an decrease of -60.00% EPS, and decrease of -6.79% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Definium Therapeutics, Inc. Common Shares
Report Date
Nov 09, 2026 For Q3 26
Estimate
-$0.56
Actual
-$0.46
Surprise
+19.06%
Ocular Therapeutix, Inc.
Report Date
Nov 09, 2026 For Q3 26
Estimate
-$0.36
Actual
-$0.42
Surprise
-13.54%
Harrow, Inc. Common Stock
Report Date
Nov 09, 2026 For Q3 26
Estimate
$0.22
Actual
$0.12
Surprise
-45.92%
SIGA Technologies Inc.
Report Date
Nov 09, 2026 For Q3 26
Estimate
-Actual
-$0.04
Surprise
-
Protara Therapeutics, Inc. Common Stock
Report Date
Nov 06, 2026 For Q3 26
Estimate
-$0.37
Actual
-$0.35
Surprise
+6.17%
Minerva Neurosciences, Inc
Report Date
Nov 06, 2026 For Q3 26
Estimate
-$0.12
Actual
$1.94
Surprise
+1,629.97%
Tonix Pharmaceuticals Holding Corp.
Report Date
Nov 09, 2026 For Q3 26
Estimate
-$2.40
Actual
-$2.89
Surprise
-20.23%
Cumberland Pharmaceuticals Inc
Report Date
Nov 10, 2026 For Q3 26
Estimate
-Actual
-$0.07
Surprise
-
PMV Pharmaceuticals, Inc
Report Date
Nov 10, 2026 For Q3 26
Estimate
-$0.34
Actual
-$0.28
Surprise
+15.55%
Corbus Pharmaceuticals Holdings, Inc.
Report Date
Nov 10, 2026 For Q3 26
Estimate
-$1.23
Actual
-$1.81
Surprise
-46.07%
FAQ
What were Cosmos Holdings Inc. Common Stock's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Cosmos Holdings Inc. Common Stock reported EPS of -$0.10, missing estimates by -1080.39%, and revenue of $18.99M, -4.15% below expectations.
How did the market react to Cosmos Holdings Inc. Common Stock's Q2 2026 earnings?
The stock price moved down -6.58%, changed from $0.21 before the earnings release to $0.19 the day after.
When is Cosmos Holdings Inc. Common Stock expected to report next?
The next earning report is scheduled for Nov 17, 2026.
What are the forecasts for Cosmos Holdings Inc. Common Stock's next earnings report?
Based on --
analysts, Cosmos Holdings Inc. Common Stock is expected to report EPS of -$0.04 and revenue of $17.70M for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.